| systematic review | Q1504425 |
| scholarly article | Q13442814 |
| P50 | author | Deborah Marshall | Q38544106 |
| Cheryl R. Barnabe | Q43020808 | ||
| Glen Hazlewood | Q56797844 | ||
| P2093 | author name string | Peter Faris | |
| Diane Lacaille | |||
| Nanette Alvarez | |||
| Alexa Smith | |||
| Stephanie Keeling | |||
| Claire E. H. Barber | |||
| G. B. John Mancini | |||
| J. Antonio Aviña-Zubieta | |||
| John M. Esdaile | |||
| Liam O. Martin | |||
| Raheem Noormohamed | |||
| P2860 | cites work | 2012 update of the 2008 American College of Rheumatology recommendations for the use of disease-modifying antirheumatic drugs and biologic agents in the treatment of rheumatoid arthritis | Q26828418 |
| General cardiovascular risk profile for use in primary care: the Framingham Heart Study | Q29614189 | ||
| Methods for the guideline-based development of quality indicators--a systematic review | Q30515048 | ||
| EULAR evidence-based recommendations for cardiovascular risk management in patients with rheumatoid arthritis and other forms of inflammatory arthritis | Q33505914 | ||
| Quality of care in systemic lupus erythematosus: the association between process and outcome measures in the Lupus Outcomes Study | Q33981158 | ||
| Guidelines for the primary prevention of stroke: a guideline for healthcare professionals from the American Heart Association/American Stroke Association | Q34153132 | ||
| ESC/EAS Guidelines for the management of dyslipidaemias The Task Force for the management of dyslipidaemias of the European Society of Cardiology (ESC) and the European Atherosclerosis Society (EAS). | Q34212424 | ||
| AGREE II: advancing guideline development, reporting and evaluation in health care | Q34403979 | ||
| Risk of cardiovascular mortality in patients with rheumatoid arthritis: a meta-analysis of observational studies | Q34889152 | ||
| Measuring process of arthritis care: the Arthritis Foundation's quality indicator set for rheumatoid arthritis | Q36388237 | ||
| Predicting cardiovascular risk in England and Wales: prospective derivation and validation of QRISK2. | Q36738148 | ||
| Suboptimal cardiovascular risk factor identification and management in patients with rheumatoid arthritis: a cohort analysis | Q36907729 | ||
| Management of cardiovascular risk in patients with rheumatoid arthritis: evidence and expert opinion | Q37058791 | ||
| Prevalence of comorbidities in rheumatoid arthritis and evaluation of their monitoring: results of an international, cross-sectional study (COMORA). | Q37465556 | ||
| Effects of evidence-based clinical practice guidelines on quality of care: a systematic review | Q37610647 | ||
| Monitoring adverse events of low-dose glucocorticoid therapy: EULAR recommendations for clinical trials and daily practice. | Q37778663 | ||
| Lack of cardiovascular risk assessment in inflammatory arthritis and systemic lupus erythematosus patients at a tertiary care center | Q37866668 | ||
| Risk factors for cardiovascular disease in rheumatoid arthritis | Q37976283 | ||
| European Guidelines on cardiovascular disease prevention in clinical practice (version 2012): The Fifth Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice (constituted | Q38018762 | ||
| 2012 update of the Canadian Cardiovascular Society guidelines for the diagnosis and treatment of dyslipidemia for the prevention of cardiovascular disease in the adult | Q38076875 | ||
| Measuring quality of care: considering conceptual approaches to quality indicator development and evaluation | Q38135667 | ||
| Joint British Societies' consensus recommendations for the prevention of cardiovascular disease (JBS3). | Q38199288 | ||
| Leflunomide and hypertension | Q43051153 | ||
| Statin use in rheumatoid arthritis in relation to actual cardiovascular risk: evidence for substantial undertreatment of lipid-associated cardiovascular risk? | Q43255462 | ||
| Development of healthcare quality indicators for rheumatoid arthritis in Europe: the eumusc.net project | Q43493651 | ||
| Tocilizumab monotherapy versus adalimumab monotherapy for treatment of rheumatoid arthritis (ADACTA): a randomised, double-blind, controlled phase 4 trial | Q44165611 | ||
| The risk of myocardial infarction in rheumatoid arthritis and diabetes mellitus: a Danish nationwide cohort study | Q45792532 | ||
| Risk of incident cardiovascular events in patients with rheumatoid arthritis: a meta-analysis of observational studies. | Q46003173 | ||
| Challenges of cardiovascular risk assessment in the routine rheumatology outpatient setting: an observational study of 110 rheumatoid arthritis patients. | Q51211966 | ||
| British Society for Rheumatology and British Health Professionals in Rheumatology guideline for the management of rheumatoid arthritis (after the first 2 years). | Q51853711 | ||
| Effectiveness-based guidelines for the prevention of cardiovascular disease in women--2011 update: a guideline from the american heart association. | Q55053962 | ||
| Immediate and past cumulative effects of oral glucocorticoids on the risk of acute myocardial infarction in rheumatoid arthritis: a population-based study | Q58160099 | ||
| BSR and BHPR rheumatoid arthritis guidelines on safety of anti-TNF therapies | Q58327972 | ||
| P433 | issue | 2 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | cardiovascular disease | Q389735 |
| rheumatoid arthritis | Q187255 | ||
| best practice | Q830382 | ||
| systematic review | Q1504425 | ||
| disease prevention | Q106807541 | ||
| P304 | page(s) | 169-79 | |
| P577 | publication date | 2015-02-01 | |
| P1433 | published in | Arthritis Care and Research | Q15754720 |
| P1476 | title | Best practices for cardiovascular disease prevention in rheumatoid arthritis: a systematic review of guideline recommendations and quality indicators | |
| P478 | volume | 67 |
| Q54964247 | A randomized controlled cross-over trial investigating the effect of anti-inflammatory diet on disease activity and quality of life in rheumatoid arthritis: the Anti-inflammatory Diet In Rheumatoid Arthritis (ADIRA) study protocol. |
| Q36746012 | Accelerated atherosclerosis in patients with chronic inflammatory rheumatologic conditions |
| Q47988471 | Assessment of six cardiovascular risk calculators in Mexican mestizo patients with rheumatoid arthritis according to the EULAR 2015/2016 recommendations for cardiovascular risk management. |
| Q38950371 | Cardiovascular disease in patients with rheumatoid arthritis |
| Q38990549 | Comparison of comorbidities of the Egyptian rheumatoid arthritis patients to the global cohort of the COMORA study: a post-hoc analysis. |
| Q33725505 | Concomitant Use of Statins in Tocilizumab-Treated Patients with Rheumatoid Arthritis: A Post Hoc Analysis |
| Q36593810 | Development of Cardiovascular Quality Indicators for Rheumatoid Arthritis: Results from an International Expert Panel Using a Novel Online Process |
| Q40379963 | Fragility Fractures Are Associated with an Increased Risk for Cardiovascular Events in Women and Men with Rheumatoid Arthritis: A Population-based Study |
| Q45971268 | Hepatic Proteins and Inflammatory Markers in Rheumatoid Arthritis Patients. |
| Q38844078 | Implementing an Electronic Medical Record-Based Reminder for Cardiovascular Risk Screening in Rheumatoid Arthritis. |
| Q38972344 | Management of Cardiovascular Risk in Patients with Chronic Inflammatory Diseases: Current Evidence and Future Perspectives. |
| Q88310736 | Managing premature atherosclerosis in patients with chronic inflammatory diseases |
| Q47929039 | Metabolic abnormalities in rheumatoid arthritis patients with comorbid diabetes mellitus. |
| Q64093765 | Plasma from Patients with Rheumatoid Arthritis Reduces Nitric Oxide Synthesis and Induces Reactive Oxygen Species in A Cell-Based Biosensor |
| Q39082330 | Primary Care Screening and Comorbidity Management in Rheumatoid Arthritis in Ontario, Canada. |
| Q36970912 | Rheumatologist and Primary Care Management of Cardiovascular Disease Risk in Rheumatoid Arthritis: Patient and Provider Perspectives. |
| Q36215851 | Self-reported quality care for knee osteoarthritis: comparisons across Denmark, Norway, Portugal and the UK |
| Q48152632 | Simple screening tools predict death and cardiovascular events in patients with rheumatic disease. |
| Q36027291 | Therapeutic potential of folic acid supplementation for cardiovascular disease prevention through homocysteine lowering and blockade in rheumatoid arthritis patients. |
Search more.